Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 121 AL 135

Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance

Smith LM, Kostylev MA, Lee S, Strittmatter SM.

J Biol Chem. 2019 Apr 12;294(15):6042-6053. doi: 10.1074/jbc.RA118.006252. Epub 2019 Feb 20.

Stress and Alzheimer's disease

Escher CM, Sannemann L, Jessen F.

J Neural Transm (Vienna). 2019 Sep;126(9):1155-1161. doi: 10.1007/s00702-019-01988-z. Epub 2019 Feb 20.

Comparative Serum Proteomic Analysis of the Effects of Sodium Selenate on a Mouse Model of Alzheimer's Disease

Chen P, Wang LX, Sui XJ, Li SM, Wang Y, Liu Q, Ni JZ.

Biol Trace Elem Res. 2019 Dec;192(2):263-276. doi: 10.1007/s12011-019-01676-9. Epub 2019 Feb 21.

Genetic discoveries and advances in late-onset Alzheimer's disease

Rezazadeh M, Hosseinzadeh H, Moradi M, Salek Esfahani B, Talebian S, Parvin S, Gharesouran J.

J Cell Physiol. 2019 Aug;234(10):16873-16884. doi: 10.1002/jcp.28372. Epub 2019 Feb 20.

Reliably Assessing Language Function in Dementia in the 21st Century

Verma M.

Am J Geriatr Psychiatry. 2019 Apr;27(4):378-380. doi: 10.1016/j.jagp.2019.01.016. Epub 2019 Jan 21.

The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications

Arranz AM, De Strooper B.

Lancet Neurol. 2019 Apr;18(4):406-414. doi: 10.1016/S1474-4422(18)30490-3. Epub 2019 Feb 19.

Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease

Li R, Zhang Y, Rasool S, Geetha T, Babu JR.

Oxid Med Cell Longev. 2019 Jan 17;2019:8165707. doi: 10.1155/2019/8165707. eCollection 2019.

Regulation of AβPP Glycosylation Modification and Roles of Glycosylation on AβPP Cleavage in Alzheimer's Disease

Tao PF, Huang HC.

ACS Chem Neurosci. 2019 May 15;10(5):2115-2124. doi: 10.1021/acschemneuro.8b00574. Epub 2019 Mar 7.

Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity

Mullane K, Williams M.

Curr Protoc Pharmacol. 2019 Mar;84(1):e57. doi: 10.1002/cpph.57. Epub 2019 Feb 25.

Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease

Jha NK, Jha SK, Kar R, Nand P, Swati K, Goswami VK.

J Neurochem. 2019 Jul;150(2):113-137. doi: 10.1111/jnc.14687. Epub 2019 Mar 26.

Low-intensity focused ultrasound for the treatment of brain diseases: safety and feasibility

Toccaceli G, Barbagallo G, Peschillo S.

Theranostics. 2019 Jan 1;9(2):537-539. doi: 10.7150/thno.31765. eCollection 2019.

Hyperphagia in Alzheimer's disease, its transient nature, and potentially reversible causes

Leung WC, Shea YF, Lee SC, Chu LW.

Psychogeriatrics. 2019 Nov;19(6):619-621. doi: 10.1111/psyg.12432. Epub 2019 Feb 27.

The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease

Cook EK, Sell GL, Schaffer TB, Margolis SS.

Expert Opin Ther Targets. 2019 Apr;23(4):263-265. doi: 10.1080/14728222.2019.1586884. Epub 2019 Mar 5.

Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress

Smith CJ, Ashford JW, Perfetti TA.

J Alzheimers Dis. 2019;68(3):885-923. doi: 10.3233/JAD-181089.

Panax ginseng components and the pathogenesis of Alzheimer's disease (Review)

Razgonova MP, Veselov VV, Zakharenko AM, Golokhvast KS, Nosyrev AE, Cravotto G, Tsatsakis A, Spandidos DA.

Mol Med Rep. 2019 Apr;19(4):2975-2998. doi: 10.3892/mmr.2019.9972. Epub 2019 Feb 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias